Latest News

GSK joins AstraZeneca and Labcyte to develop acoustic mass spectrometry

GSK has joined forces with AstraZeneca and Labcyte to combine acoustic liquid dispensing technology with mass spectrometry (MS) for use in high throughput small molecule screening and other...

GSK joins AstraZeneca and Labcyte to develop acoustic mass spectrometry

Deals this week: Aspen Global Incorporated, Zhejiang Conba Pharmaceutical, Teva Pharmaceutical Industries

Mauritius-based holding company Aspen Global Incorporated (AGI) has signed an agreement with AstraZeneca to acquire the rights to the latter’s anaesthetic treatments portfolio for...

Deals this week: Aspen Global Incorporated, Zhejiang Conba Pharmaceutical, Teva Pharmaceutical Industries

Novartis’ Rydapt receives approval for two cancer treatments in the EU

Novartis’ Rydapt receives approval for two cancer treatments in the EU

M&As this week: Catalent, Ultragenyx Pharmaceutical

Catalent has announced plans to acquire Cook Pharmica for...

M&As this week: Catalent, Ultragenyx Pharmaceutical

Recipharm and Roche sign agreement to manufacture solid dose products

Swedish pharmaceutical company Recipharm has signed a long-term manufacturing agreement with Roche to produce a wide range of solid dose...

Recipharm and Roche sign agreement to manufacture solid dose products

Pfizer files lawsuit against J&J’s exclusionary contracts for Remicade

Pfizer has filed a lawsuit against Johnson & Johnson (J&J) in the US District Court for the Eastern District of Pennsylvania to ensure patients and providers have access to major,...

Pfizer files lawsuit against J&J’s exclusionary contracts for Remicade

NICE recommends Bristol-Myers Squibb’s nivolumab for NSCLC patients on NHS

NICE recommends Bristol-Myers Squibb’s nivolumab for NSCLC patients on NHS

Zydus and Pharm Aid enter deal for varicella vaccine technology in Russia

Indian healthcare company Zydus Cadila has entered an exclusive agreement with Pharm Aid for the technology expertise of varicella vaccine production in Russia to prevent...

Zydus and Pharm Aid enter deal for varicella vaccine technology in Russia

Catalent signs agreement to buy Cook Pharmica for $950m

Catalent signs agreement to buy Cook Pharmica for $950m

New study suggests jet lag drug benefits patients undergoing chemotherapy

A recent study conducted by scientists at the Universities of Edinburgh and Aberdeen has suggested that painful side effects from cancer medicines can be managed using melatonin, a drug that...

New study suggests jet lag drug benefits patients undergoing chemotherapy

Teva to sell assets in global women’s health business for $1.38bn

Teva Pharmaceutical Industries has entered two agreements to divest the remaining stake in its specialist global women’s health business for...

Teva to sell assets in global women’s health business for $1.38bn

NUS study shows Artemisinin-ALA co-treatment could destroy cancer cells

NUS study shows Artemisinin-ALA co-treatment could destroy cancer cells

Gates Foundation supports development of Immunocore’s therapeutics for infectious diseases

Immunocore has secured up to $40m in investment from Bill & Melinda Gates Foundation to boost the development of soluble T-cell receptor (TCR)-based therapeutics to treat infectious diseases,...

Gates Foundation supports development of Immunocore’s therapeutics for infectious diseases

Amgen and Allergan’s anti-cancer biosimilar Mvasi receives FDA approval

The US Food and Drug Administration (FDA) has approved Mvasi (bevacizumab-awwb) for the treatment of five types of...

Amgen and Allergan’s anti-cancer biosimilar Mvasi receives FDA approval

GSK and Innoviva receive positive opinion from CHMP for Trelegy Ellipta to treat COPD

GSK and Innoviva receive positive opinion from CHMP for Trelegy Ellipta to treat COPD

Aspen to acquire remaining rights to AstraZeneca’s anaesthetic medicines

Aspen Global Incorporated (AGI) has entered an agreement to acquire all the remaining rights to AstraZeneca’s established anaesthetic treatments for an upfront consideration of...

Aspen to acquire remaining rights to AstraZeneca’s anaesthetic medicines

Evotec and MaRS Innovation launch new drug-discovery partnership

German company Evotec and Canada-based MaRS Innovation (MI) have launched a joint partnership ‘LAB150’ in Toronto, Ontario,...

Evotec and MaRS Innovation launch new drug-discovery partnership

Deals this week: Pivot Pharmaceuticals, Innovation Pharmaceuticals, Portola Pharmaceuticals

Pivot Pharmaceuticals plans to acquire the worldwide rights to Altum Pharmaceuticals’ BiPhasix Transdermal drug delivery...

Deals this week: Pivot Pharmaceuticals, Innovation Pharmaceuticals, Portola Pharmaceuticals

M&As this week: Silver Falcon, Adcock Ingram Holdings, Boya Bio-pharmaceutical Group

Financial services provider Silver Falcon plans to acquire biotechnology company Hemogenyx Pharmaceuticals (Hemogenyx Pharma) for £8m...

M&As this week: Silver Falcon, Adcock Ingram Holdings, Boya Bio-pharmaceutical Group

Bristol-Myers and Halozyme to develop subcutaneous immuno-oncology drugs

Bristol-Myers Squibb has entered a global collaboration and licence agreement to use Halozyme Therapeutics’ Enhanze drug-delivery technology for the development of its subcutaneously...

Bristol-Myers and Halozyme to develop subcutaneous immuno-oncology drugs

Monopar receives licence to develop Onxeo’s Validive oral mucositis treatment

Onxeo has granted a global exclusive licence to Monopar Therapeutics for its Validive (clonidine mucoadhesive buccal) tablet used to treat severe oral mucositis induced by radiotherapy...

Monopar receives licence to develop Onxeo’s Validive oral mucositis treatment
cachename:Newscachekey:rd-1665407042_1857678299_rd-488908060_1460672566_rd1460672566_371857150_ap1460672566_1857678299_-520784304